BDBM225902 3-(6-{[(1r)-1- cyclobutylethyl]amino}-8-[1- (2,5-dimethyl-1,3-thiazol-4- yl)cyclopropyl]-7-[(trans-4- methylcyclohexyl)methyl]- 7h-purin-2-yl)-1,2,4- oxadiazol-5(4h)-one::US9540377, 22.72

SMILES Cc1nc(C2(c3nc4nc(-c5noc(=O)[nH]5)nc(N[C@H](C)C5CCC5)c4n3C[C@H]3CC[C@H](C)CC3)CC2)c(C)s1

InChI Key InChIKey=FLTZBIKWNTZPOP-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 225902   

TargetE3 ubiquitin-protein ligase Mdm2 [17-125](Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 225902BDBM225902(US9540377, 22.72 | 3-(6-{[(1r)-1- cyclobutylethyl]...)
Affinity DataIC50: 3.04nMT: 2°CAssay Description:An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2018
Entry Details
US Patent